Health phenome of Parkinson’s patients reveals prominent mood-sleep cluster

Abstract Background: Associations between phenotypic traits, environmental exposures, and Parkinson’s disease have largely been evaluated one-by-one, piecemeal, and pre-selections. A comprehensive picture of comorbidities, phenotypes, exposures, and polypharmacy characterizing the complexity and heterogeneity of real-world patients presenting to academic movement disorders clinics in the US is missing. Objectives: To portrait the complexity of features associated with patients with Parkinson’s disease in a study of 933 cases and 291 controls enrolled in the Harvard Biomarkers Study. Methods: The primary analysis evaluated 64 health features for associations with Parkinson’s using logistic regression adjusting for age and sex. We adjusted for multiple testing using the false discovery rate (FDR) with £ 0.05 indicating statistical significance. Exploratory analyses examined feature correlation clusters and feature combinations. Results: Depression (OR = 3.11, 95% CI 2.1 to 4.71), anxiety (OR = 3.31, 95% CI 2.01-5.75), sleep apnea (OR 2.58, 95% CI 1.47-4.92), and restless leg syndrome (RLS; OR 4.12, 95% CI 1.81-12.1) were significantly more common in patients with Parkinson’s than in controls adjusting for age and sex with FDR £ 0.05. The prevalence of depression, anxiety, sleep apnea, and RLS were correlated, and these diseases formed part of a larger cluster of mood traits and sleep traits linked to PD. Exposures to pesticides (OR 1.87, 95% CI 1.37-2.6), head trauma (OR 2.33, 95% CI 1.51-3.73), and smoking (OR 0.57, 95% CI 0.43-0.75) were significantly associated with the disease consistent with previous studies. Vitamin supplementation with cholecalciferol (OR 2.18, 95% CI 1.4-3.45) and coenzyme Q10 (OR 2.98, 95% CI 1.89-4.92) was more commonly used by patients than controls. Cumulatively, 43% (398 of 933) of Parkinson’s patients had at least one psychiatric or sleep disorder, compared to 21% (60 of 291) of healthy controls. Conclusions: 43% of Parkinson’s patients seen at Harvard-affiliated teaching hospitals have depression, anxiety, and disordered sleep. This syndromic cluster of mood and sleep traits may be pathophysiologically linked and clinically important..

Medienart:	Preprint

Erscheinungsjahr:	2024
Erschienen:	2024

Enthalten in:	ResearchSquare.com - (2024) vom: 31. Jan. Zur Gesamtaufnahme - year:2024

Sprache:	Englisch

Beteiligte Personen:

Olsen, Abby [VerfasserIn] Locascio, Joseph [VerfasserIn] Tuncali, Idil [VerfasserIn] Laroussi, Nada [VerfasserIn] Abatzis, Elena [VerfasserIn] Kamenskaya, Polina [VerfasserIn] Kuras, Yuliya [VerfasserIn] Yi, Tom [VerfasserIn] Videnovic, Aleks [VerfasserIn] Hayes, Michael [VerfasserIn] Ho, Gary [VerfasserIn] Paulson, Jordan [VerfasserIn] Khurana, Vikram [VerfasserIn] Herrington, Todd [VerfasserIn] Hyman, Bradley [VerfasserIn] Selkoe, Dennis [VerfasserIn] Growdon, John [VerfasserIn] Gomperts, Stephen [VerfasserIn] Riise, Trond [VerfasserIn] Schwarzschild, Michael [VerfasserIn] Hung, Albert [VerfasserIn] Wills, Anne [VerfasserIn] Scherzer, Clemens [VerfasserIn]

Links:	Volltext [kostenfrei]

Themen:	570 Biology

doi:	10.21203/rs.3.rs-3683455/v1

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	XRA04196733X